Envue Medical Inc. has announced an amended and restated employment agreement with its Chief Executive Officer, Dr. Doron Besser. Under the new agreement, Dr. Besser will receive an annual salary of $360,000. Additionally, he will be granted 180,000 restricted stock units, representing 9% of the company’s fully diluted common stock as of the agreement’s effective date. On each annual anniversary of the initial grant, Dr. Besser will receive additional restricted stock units to maintain his 9% equity interest, provided he remains employed by the company. In the event of termination without cause or resignation for good reason, or following a change in control, Dr. Besser is eligible for a one-time payment equal to 12 months of his base salary, along with severance pay and certain pension and insurance contributions. The agreement also includes customary provisions regarding non-solicitation, non-competition, confidentiality, and benefits for transport and technology expenses.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Envue Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-029018), on December 23, 2025, and is solely responsible for the information contained therein.